Evidence map›Paper›PMID 38515537›Full record

ArticleFrontiers in veterinary science2024

Hattan S Gattan, Majed H Wakid, Rowaid M Qahwaji, Sarah Altwaim, Haifaa A Mahjoub, Mashael S Alfaifi, Hayam Elshazly, Wafa Abdullah I Al-Megrin, Eman Abdullah Alshehri, Hatem A Elshabrawy and 1 more

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Hattan S GattanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Majed H WakidDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Rowaid M QahwajiDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Sarah AltwaimSpecial Infectious Agents Unit, King Fahd Medical Research Center, Jeddah, Saudi Arabia.
Haifaa A MahjoubBiological Sciences Department, College of Sciences and Arts, King Abdulaziz University, Rabigh, Saudi Arabia.
Mashael S AlfaifiDepartment of Epidemiology, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Mecca, Saudi Arabia.
Hayam ElshazlyDepartment of Biology, Faculty of Sciences-Scientific Departments, Qassim University, Buraidah, Saudi Arabia.
Wafa Abdullah I Al-MegrinDepartment of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Eman Abdullah AlshehriDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Hatem A ElshabrawyDepartment of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX, United States.
Asmaa M El-KadyDepartment of Medical Parasitology, Faculty of Medicine, South Valley University, Qena, Egypt.
King Abdulaziz University · SAKing Fahad Hospital Jeddah · SABeni-Suef University · EGKing Saud University · SAPrincess Nourah bint Abdulrahman University · SASam Houston State University · USSouth Valley University · EGUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cryptosporidiosis is an opportunistic parasitic disease widely distributed worldwide. Although Materials and methods: The Results: treatment with EUG resulted in a significant reduction in the number of oocysts secreted in stool when compared to infected untreated mice. In addition, oocyst excretion was significantly reduced in mice received a combination therapy of EUG and NTZ when compared with those received NTZ alone. EUG succeeded in reverting the histopathological alterations induced by Conclusion: Based on the results, the present study signified a basis for utilizing EUG as an affordable, safe, and alternative therapy combined with NTZ in the management of cryptosporidiosis.

Indexed as

CryptosporidiumeugenolimmunocompromisediNOSnitazoxanide

Identifiers

PMID38515537
PMCPMC10954888
OpenAlexW4392559742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.